Cargando…
SUMOylation in Glioblastoma: A Novel Therapeutic Target
Protein SUMOylation is a dynamic post-translational modification which is involved in a diverse set of physiologic processes throughout the cell. Of note, SUMOylation also plays a role in the pathobiology of a myriad of cancers, one of which is glioblastoma (GBM). Accordingly, herein, we review core...
Autores principales: | Fox, Brandon M., Janssen, Andrew, Estevez-Ordonez, Dagoberto, Gessler, Florian, Vicario, Nunzio, Chagoya, Gustavo, Elsayed, Galal, Sotoudeh, Houman, Stetler, William, Friedman, Gregory K., Bernstock, Joshua D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514907/ https://www.ncbi.nlm.nih.gov/pubmed/30991648 http://dx.doi.org/10.3390/ijms20081853 |
Ejemplares similares
-
Artificial Intelligence in the Management of Glioma: Era of Personalized Medicine
por: Sotoudeh, Houman, et al.
Publicado: (2019) -
Cauda equina syndrome in an ovarian malignant‐mixed müllerian tumor with leptomeningeal spread
por: Bernstock, Joshua D., et al.
Publicado: (2019) -
Intraventricular metastatic melanoma: A case report and review of the literature
por: Bernstock, Joshua D., et al.
Publicado: (2020) -
Drugging SUMOylation for neuroprotection and oncotherapy
por: Bernstock, Joshua D., et al.
Publicado: (2018) -
Impact of Anesthetic Variation in Endovascular Treatment of Acute Ischemic Stroke
por: Salehani, Arsalaan, et al.
Publicado: (2020)